Journal of Movement Disorders

Sindana D. Ilango

1 Article

Environmental Risk Factors for Progressive Supranuclear Palsy: Hee Kyung Park, Sindana D. Ilango, Irene Litvan; J Mov Disord. 2021;14(2):103-113. Published online May 26, 2021; DOI: https://doi.org/10.14802/jmd.20173

13,745 View
330 Download
9 Web of Science
13 Crossref

Typically, progressive supranuclear palsy (PSP) is clinically characterized by slow vertical saccades or supranuclear gaze palsy, levodopa-resistant parkinsonism with predominant axial symptoms, and cognitive executive impairment. Over the past decades, various PSP phenotypes, including PSP with predominant parkinsonism, PSP with corticobasal syndrome, PSP with progressive gait freezing, and PSP with predominant frontal dysfunction, have been identified from pathologically confirmed cases. Expanding knowledge led to new diagnostic criteria for PSP that with increased disease awareness led to increased PSP prevalence estimates. The identification of environmental and modifiable risk factors creates an opportunity to intervene and delay the onset of PSP or slow disease progression. To date, despite the increasing number of publications assessing risk factors for PSP, few articles have focused on environmental and lifestyle risk factors for this disorder. In this article, we reviewed the literature investigating the relationship between PSP and several environmental and other modifiable lifestyle risk factors. In our review, we found that exposures to toxins related to diet, metals, well water, and hypertension were associated with increased PSP risk. In contrast, higher education and statins may be protective. Further case-control studies are encouraged to determine the exact role of these factors in the etiopathogenesis of PSP, which in turn would inform strategies to prevent and reduce the burden of PSP.

Citations

Citations to this article as recorded by

Misdiagnosis of Frontotemporal Dementia in a Patient With Progressive Supranuclear Palsy: A Case Report and Volumetric Neuroimaging Application
Camila B Eguiguren, Mateo D Fabara, Amelia Diaz
Cureus.2025;[Epub] CrossRef
Parkinson’s Disease is Predominantly a Genetic Disease
Shen-Yang Lim, Christine Klein
Journal of Parkinson’s Disease.2024; 14(3): 467. CrossRef
Progressive supranuclear palsy, a case report
A. Ortiz, F. Troya, J. de Vera, E. Vázquez
Archivos de la Sociedad Española de Oftalmología (English Edition).2024; 99(7): 304. CrossRef
Progressive Supranuclear Palsy Syndrome: An Overview
Eduardo Ichikawa-Escamilla, Rodrigo A. Velasco-Martínez, Laura Adalid-Peralta
IBRO Neuroscience Reports.2024; 16: 598. CrossRef
The Role of MicroRNAs in Progressive Supranuclear Palsy—A Systematic Review
Aleksandra Ćwiklińska, Grzegorz Procyk, Dariusz Koziorowski, Stanisław Szlufik
International Journal of Molecular Sciences.2024; 25(15): 8243. CrossRef
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
Yura Jang, Sungtaek Oh, Anna J. Hall, Zhen Zhang, Thomas F. Tropea, Alice Chen-Plotkin, Liana S. Rosenthal, Ted M. Dawson, Chan Hyun Na, Alexander Y. Pantelyat
Clinical Proteomics.2024;[Epub] CrossRef
The Effect of Alcohol Consumption on Progressive Supranuclear Palsy: A Cross‐Sectional Study
Min Tian, Bohan Zhang, Heyin Liu, Yinlian Han, Mu Yang, Ruonan Duan, Dandan Guo, Chengyuan Song, Jun Ma, Yiming Liu
CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel
Yael Barer, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich, Gabriel Chodick
Journal of Neurology.2023; 270(8): 3770. CrossRef
The Pesticide Chlordecone Promotes Parkinsonism-like Neurodegeneration with Tau Lesions in Midbrain Cultures and C. elegans Worms
Valeria Parrales-Macias, Patrick P. Michel, Aurore Tourville, Rita Raisman-Vozari, Stéphane Haïk, Stéphane Hunot, Nicolas Bizat, Annie Lannuzel
Cells.2023; 12(9): 1336. CrossRef
The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis
Shane Lyons, Dominic Trépel, Tim Lynch, Richard Walsh, Sean O’Dowd
Journal of Neurology.2023; 270(9): 4451. CrossRef
Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy
Aliz Persely, Beatrix Beszedics, Krisztina Paloczi, Marton Piroska, Amirreza Alijanpourotaghsara, David Strelnikov, Arsalan Vessal, Helga Szabo, Anita Hernyes, Luca Zoldi, Zsofia Jokkel, Andrea Fekete, Janos Juhasz, Nora Makra, Dora Szabo, Edit Buzas, Ada
Medicina.2023; 59(10): 1696. CrossRef
Dementia Prevention in Clinical Practice
Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton, Richard Isaacson
Seminars in Neurology.2022; 42(05): 525. CrossRef
Progressive Supranuclear Palsy in 2022: recent developments and an eye to the future
Shane Lyons, Sean O'Dowd, Richard Walsh, Tim Lynch
Advances in Clinical Neuroscience & Rehabilitation.2022;[Epub] CrossRef

Author index